Clinical Trial: A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients with Osteoarthritis of the Hip.

This study is no longer recruiting patients.

Sponsored by: Genzyme
Information provided by: Genzyme
ClinicalTrials.gov Identifier: NCT00131326

Purpose

This is a clinical study to investigate the safety and efficacy of Synvisc and Depo-Medrol in treating patients with osteoarthritis (OA) of the hip.
Condition Intervention Phase
osteoarthritis of the hip
musculoskeletal
 Device: Synvisc (hylan G-F 20)
Phase III

MedlinePlus related topics:  Osteoarthritis

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Further Study Details: 
Primary Outcomes: Pain relief

Study start: November 2003;  Study completion: September 2006
Last follow-up: April 2006;  Data entry closure: June 2006

Eligibility

Ages Eligible for Study:  35 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

Exclusion Criteria:

  • patients with current or prior conditions or treatment that would impede measurement of efficacy and safety

Location Information


Alabama
      Sports Medicine, Huntsville,  Alabama,  35802,  United States

      Alabama Clinical Therapeutics, Birmingham,  Alabama,  35235,  United States

Arizona
      Affiliated Orthopedic Specialists, Scottsdale,  Arizona,  85260,  United States

Arkansas
      Arkansas Orthopaedic Specialists, Little Rock,  Arkansas,  72205,  United States

California
      Sharp Healthcare, San Diego,  California,  92123,  United States

      Jackson Arthritis Center, Oakland,  California,  94609,  United States

      Kerlan Jobe Orthopedic Clinic, Los Angeles,  California,  90045,  United States

Florida
      Orthopedic Institute at Mercy Hospital, Miami,  Florida,  33133,  United States

      Orthopedic Specialists, Clearwater,  Florida,  33756,  United States

Idaho
      Idaho Arthritis & Osteoporosis Center, Meridian,  Idaho,  83642,  United States

Illinois
      Illinois Bone and Joint Institute, Ltd., Morton Grove,  Illinois,  60053,  United States

      Northwestern Orthopaedic Institute, Chicago,  Illinois,  60611,  United States

Iowa
      Physician''''s Clinic of Iowa, Cedar Rapids,  Iowa,  52401-2152,  United States

Kansas
      Kansas City Orthopedic Group, Leawood,  Kansas,  66211,  United States

Kentucky
      Bluegrass Orthopaedics, Lexington,  Kentucky,  40509,  United States

Louisiana
      Special Surgery Center, Shreveport,  Louisiana,  71109,  United States

Maryland
      Johns Hopkins University, Baltimore,  Maryland,  21239,  United States

Michigan
      Family Orthopedic Associates, Flint,  Michigan,  48507,  United States

New Jersey
      UMDNJ-RWJ University Orthopedic Group, New Brunswick,  New Jersey,  08901,  United States

New York
      Hospital for Special Surgery, New York,  New York,  10021,  United States

Ohio
      Hughston Sports Medicine Foundation, Columbus,  Ohio,  31909,  United States

Oklahoma
      Health Research Institute, Oklahoma City,  Oklahoma,  73109,  United States

Oregon
      Orthopedic Ctr for Joint Replacement & Sports Medicine, Grants Pass,  Oregon,  97527,  United States

Pennsylvania
      Altoona Center for Clinical Research, Duncansville,  Pennsylvania,  16635,  United States

      Allegheny Orthopedic Associates, Pittsburgh,  Pennsylvania,  15212,  United States

      Lancaster Orthopedic Group, Lancaster,  Pennsylvania,  17601,  United States

South Carolina
      Conway Medical Center, Conway,  South Carolina,  29526,  United States

Tennessee
      Chattanooga Center for Sports, Chattanooga,  Tennessee,  37404,  United States

Texas
      Private Practice, Lubbock,  Texas,  79410,  United States

Virginia
      Lewis Gale Clinic, Inc., Salem,  Virginia,  24153,  United States

Washington
      Arthritis Northwest, Seattle,  Washington,  98166-2967,  United States

Study chairs or principal investigators

David Perkins,  Study Director,  Genzyme   

More Information

Study ID Numbers:  SYNV-004-02
Last Updated:  August 17, 2005
Record first received:  August 17, 2005
ClinicalTrials.gov Identifier:  NCT00131326
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13

Resources




Common Treatments

[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Follow Us